BREAKTHROUGH T1D
Data sourced from IRS 990-PF public filings
Funds research and development in Type 1 diabetes, focusing on beta cell replacement and immunotherapies, primarily supporting universities and medical research institutions in the United States.
Grants (Last Year)
$0
Total Grants on File
323
Recipients Funded
91
Giving History
| Year | Total Granted | Grants Made | Avg Grant |
|---|---|---|---|
| 2023 | $67,075,228 | 93 | $721,239 |
| 2022 | $74,336,017 | 101 | $736,000 |
| 2021 | $49,414,446 | 129 | $383,058 |
Top Grant Recipients
WESTBOROUGH, MA
CAMBRIDGE, MA
DENVER, CO
DENVER, CO
CAMBRIDGE, MA
GAINESVILLE, FL
SAN FRANCISCO, CA
GAINESVILLE, FL
SAN FRANCISCO, CA
LEHI, UT
Showing top 10 of 323 grants on file.
Officers & Trustees
From 2023 IRS 990-PF filing (data available for 2 filing years)
DRAYTON VIRKLER
BOARD MEMBER
MATT VAREY
CHAIR, AUDIT & RISK COMMITTEE
CHRISTOPHER TURNER
BOARD MEMBER
JENNIFER SCHNEIDER MD
CHAIR, NOMINATING & GOV COMMITTEE
JEFF PLUMER
BOARD MEMBER
CARLTON MCMILLAN
DIRECTOR
JOE LACHER JR
BOARD MEMBER
KAREN JORDAN
CHAIR, FUNDING COMMITTEE
CLAUDIA GRAHAM PHD
CHAIR, ADVOCACY & IMPACT COMMITTEE
ELIZABETH CASWELL
CHAIR, RESEARCH COMMITTEE
Showing 10 of 30 officers and trustees.
IRS Filing History
BREAKTHROUGH T1D has IRS 990-PF filings on record for 2 years, spanning 2022 to 2023.
Frequently Asked Questions
Other Foundations in New York
Unlock Full Foundation Data
Sign up for free to access the complete grant history, financial trends, key personnel, smart matching, and export tools.